237 related articles for article (PubMed ID: 21298326)
1. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells.
Lefort EC; Blay J
Clin Exp Metastasis; 2011 Apr; 28(4):337-49. PubMed ID: 21298326
[TBL] [Abstract][Full Text] [Related]
2. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.
Chang JH; Cheng CW; Yang YC; Chen WS; Hung WY; Chow JM; Chen PS; Hsiao M; Lee WJ; Chien MH
J Exp Clin Cancer Res; 2018 Aug; 37(1):199. PubMed ID: 30134935
[TBL] [Abstract][Full Text] [Related]
3. Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior.
Tan EY; Mujoomdar M; Blay J
Am J Pathol; 2004 Jul; 165(1):319-30. PubMed ID: 15215186
[TBL] [Abstract][Full Text] [Related]
4. Apigenin upregulation of CD26/DPPIV on colon epithelial cells requires inhibition of casein kinase 2.
Lefort ÉC; Diaconu B; Bentley VL; Blay J
Food Sci Nutr; 2020 Oct; 8(10):5321-5329. PubMed ID: 33133535
[TBL] [Abstract][Full Text] [Related]
5. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
6. Apigenin directly interacts with and inhibits topoisomerase 1 to upregulate CD26/DPP4 on colorectal carcinoma cells.
Fux JE; Lefort ÉC; Rao PPN; Blay J
Front Pharmacol; 2022; 13():1086894. PubMed ID: 36618939
[No Abstract] [Full Text] [Related]
7. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
[TBL] [Abstract][Full Text] [Related]
8. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
[TBL] [Abstract][Full Text] [Related]
9. DPPIV/CD26: a tumor suppressor or a marker of malignancy?
Beckenkamp A; Davies S; Willig JB; Buffon A
Tumour Biol; 2016 Jun; 37(6):7059-73. PubMed ID: 26943912
[TBL] [Abstract][Full Text] [Related]
10. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
11. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
Pang R; Law WL; Chu AC; Poon JT; Lam CS; Chow AK; Ng L; Cheung LW; Lan XR; Lan HY; Tan VP; Yau TC; Poon RT; Wong BC
Cell Stem Cell; 2010 Jun; 6(6):603-15. PubMed ID: 20569697
[TBL] [Abstract][Full Text] [Related]
12. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
14. Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.
Gonzalez-Gronow M; Hershfield MS; Arredondo-Vega FX; Pizzo SV
J Biol Chem; 2004 May; 279(20):20993-8. PubMed ID: 15016824
[TBL] [Abstract][Full Text] [Related]
15. CD26 Induces Colorectal Cancer Angiogenesis and Metastasis through CAV1/MMP1 Signaling.
Ng L; Wong SK; Huang Z; Lam CS; Chow AK; Foo DC; Lo OS; Pang RW; Law WL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163100
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
17. Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway.
Tan EY; Richard CL; Zhang H; Hoskin DW; Blay J
Am J Physiol Cell Physiol; 2006 Sep; 291(3):C433-44. PubMed ID: 16611738
[TBL] [Abstract][Full Text] [Related]
18. Apigenin-mediated Alterations in Viability and Senescence of SW480 Colorectal Cancer Cells Persist in The Presence of L-thyroxine.
Zohreh B; Masoumeh V; Fakhraddin N; Omrani GHR
Anticancer Agents Med Chem; 2019; 19(12):1535-1542. PubMed ID: 31272364
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
[TBL] [Abstract][Full Text] [Related]
20. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
